Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study.

Wei-Fan HsuShi-Hang YuJaw-Town LinJaw-Ching WuMing-Chih HouYi-Hsiang Huang Chun-Ying Wu Cheng-Yuan Peng

Published in: Gastroenterology research and practice (2019)

Long-term ACEi/ARB use was not associated with a higher risk of ESRD in cirrhotic patients. However, the risk of ESRD tended to increase in cirrhotic patients with ascites.

Keyphrases

angiotensin converting enzyme
end stage renal disease
angiotensin ii
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes
cell free
patient reported